TMCnet News

Powering Precision Health 2017 Announces World-Renowned Keynote Lineup
[October 17, 2017]

Powering Precision Health 2017 Announces World-Renowned Keynote Lineup


Powering Precision Health 2017 (PPHS), the nation's first precision health summit designed to be the premiere forum for world-leading researchers and clinicians, today announced its stellar keynote lineup. The summit will be held Oct. 24th and 25th at the historic Charles Hotel in Harvard Square.

"Powering Precision Health brings together world-leading innovators, scientists, physicians, advocates, government officials, and regulators to collectively address the enormous opportunity of defining wellness and preventing the progression of disease," said Kevin Hrusovsky, Founder and Chairman, PPHS 2017. "The summit is an opportunity for leading medical and scientific minds to share innovations in disease prevention, early detection and intervention strategies, and debate, defend and collaborate around key advances in personalized precision health. We will explore the role of science, sports and business media publications in educating society and influencing judgements in the court of public opinion. Breakthroughs in seeing molecular disease triggers non-invasively in blood are generating excitement around the potential for early detection of concussion, Chronic traumatic encephalopathy, Alzheimer's Disease, Multiple sclerosis, pancreatic cancer and breast cancer. Many of these advances will be unveiled and carefully explored at PPHS this year."

PPHS 2017 Keynote Lineup

Day 1: Tuesday, Oct. 24, 2017

  • The Variables of Life Can Be Measured, Evaluated, And Acted Upon to Transform "Sick Care" to "Health Care"
    • Kevin Hrusovsky, Founder and Chairman of the Powering Precision Health Summit
  • Neurology Keynote
    • Ann McKee, M.D., Professor of Neurology and Pathology, Boston University. Chief Neuropathologist for the National VA ALS Brain Bank. Director at the Neuropathology Service for the New England Veterans Administration Medical Centers (VISN-1)
  • Panel Discussion: Understanding CTE and the long-term effects of mTBI, concussions and sub-concussive hits - Implications for children, athletes, active military/veterans, and their families
    • Kevin Hrusovsky - Chairman
    • Ann McKee, M.D.
    • Ramon Diaz- Arrastia, M.D., Ph.D., Presidential Professor of Neurology, Director of Traumatic Brain Injury Clinical Research Center, University of Pennsylvania
    • Jessica Gill, Ph.D., RN, Lasker Clinical Research Scholar at Center for Neuroscience and Regenerative Medicine, National Institute of Health
    • Robert Stern, Ph.D., Professor of Neurology, Neurosurgery, and Anatomy and Neurobiology, Boston University School of Medicine
    • Chris Nowinski, Ph.D., Co-Founder and CEO, Concussion Legacy Foundation
    • Peter Cronan, CTE Research Advocate, Former Seattle Seahawks and Washington Redskins player and two-time Super Bowl Champion
  • Stopping Alzheimer's Disease: Early Detection, Early Intervention
    • Rudy Tanzi, Ph.D., Vice-Chair of Neurology and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital. Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School
  • Panel Discussion: Prevention & Detecting Degenerative Neurological Disorders
    • Kevin Hrusovsky - Chairman
    • Rudy Tanzi, Ph.D.
    • Robert Stern, Ph.D.
    • Sudha Seshadri, M.D., Professor of Neurology, Boston University School of Medicine
    • Mony de Leon, Ed.D., Founder and Director of the Center for Brain Health in the Department of Psychiatry, NYU Langone Medical Center, Professor of Psychiatry, NYU School of Medicine
    • Henrik Zetterberg, M.D., Ph.D., Professor of Neurochemistry, University of Gothenburg, Sweden, and University College London, and Department Head Psychiatry and Neurochemistry, University of Gothenburg
  • Roundtable Forum: Media's Voice in Advancing Precision Health Biomarker Innovation at the Intersection of Sports and Science for Concussion and CTE
    • Kevin Hrusovsky - Chairman
    • Ramon Diaz-Arrastia, M.D., Ph.D.
    • Christopher Borland, Founder, T-Mindful, Mental Health Advocate, Carter Center, Former San Francisco 49er linebacker
    • Tim Fox, CTE Research Advocate, Retired New England Patriots player
    • Josh Brogadir, News and Sports Reporter at WCVB
    • A.J. Perez, Staff Writer, USA TODAY Sports



Day 2: Wednesday, Oct. 25, 2017

  • Prevention, Early Detection and Improved Treatments in Neurodegenerative Diseases: The Frates Family Journey and the Ice Bucket Challenge
  • The Value of Advanced BCG Drug Development in Human Autoimmunity; Mechanistic Biomarkers for Trial Design; Vaccine for Type 1 Diabetes
    • Denise Faustman, M.D., Ph.D., Director of the Immunobiology Laboratory, Massachusetts General Hospital and Associate Professor of Medicine, Harvard Medical School
  • Panel Discussion: Improving Pace of Drug Development with Biomarkers
    • Kevin Hrusovsky - Chairman
    • Nancy Frates
    • Denise Faustman, M.D., Ph.D.
    • Alfred Sandrock, M.D., Ph.D., Executive Vice President and Chief Medical Officer, Biogen
    • Jeff Dage, Ph.D., Senior Research Advisor, Tailored Therapeutics Neuroscience, Eli Lilly & Company
    • Ramon Diaz-Arrastia, M.D., Ph.D.
  • Early Disease Detection and Precision Treatment for Pancreatic Cancer
    • Raghu Kalluri, M.D., Ph.D., Professor and Chairman Cancer Biology and Director of the Metastasis Research Center, MD Anderson Cancer Center
  • Panel Discussion: Prevention & Early Detection in Oncology; Role of Liquid Biopsies
    • Kevin Hrusovsky - Chairman
    • Raghu Kalluri, M.D., Ph.D.
    • David Walt, Ph.D., Faculty, Harvard Wyss Institute; Professor of Pathology, Harvard Medical School; and Institute Professor, Howard Hughes (News - Alert) Medical Institute
    • Gordon Freeman, Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School
    • Anthony John Iafrate, M.D., Ph.D., Professor of Pathology, Harvard Medical School Pathologist, Massachusetts General Hospital
    • Doug Williams, Ph.D., President and CEO, Codiak Biosciences
  • Roundtable Forum: Media's Voice in Advancing Investments in Precision Health Biomarker Innovation
    • Kevin Hrusovsky - Chairman
    • Lydia Ramsey, Reporter, Business Insider
    • Robert Jordan, Publisher & Editor in Chief, Drug Discovery World
    • Dr. Marijn Dekkers, Chairman of Unilever, Member of the Board of Directors at General Electric, Former CEO of Bayer and Thermo Fisher Scientific Inc.

"The Powering Precision Health Summit has become one of the most important venues to learn about the rapid, disruptive changes impacting biomarker research," said Dr. Kalluri. "I'm excited to join my colleagues at this important summit and present on how precision medicine can advance the way we diagnose and treat pancreatic cancer. I know attendees will benefit from hearing about the latest and most powerful advancements in the paradigm shift to precision health."


Powering Precision Health 2017 provides a forum for world-leading medical experts to unveil breakthrough medical research and collaborate on innovative treatments. This year's keynoters will present the foremost thinking behind this emerging movement toward quantitative, personalized health and highlight how recent innovations in science and technology are enabling researchers to discover, measure and act upon the biomarkers of life at the molecular level, realizing precision medicine.

For more information about Powering Precision Health 2017, please visit: www.pphsummit.com. To register online and attend free of charge, please visit: https://goo.gl/z1LUhq.

About Powering Precision Health

Powering Precision Health is the nation's first summit dedicated to bringing the world's top physicians, scientists, innovators, investors and patient advocates together to collaborate on the latest research on new biomarkers that are revolutionizing medicine. Founded by Kevin Hrusovsky, the acclaimed thought leader and visionary in life sciences and personalized medicine, PPHS is an executive think tank of researchers and clinicians working together to transform healthcare. Addressing key therapeutic areas including neurology, cardiology, oncology, and infectious disease - each year PPHS unveils groundbreaking approaches for prevention, early detection and diagnosis, and precision treatment of disease. Join the movement on social media with hashtag #PPHSUMMIT on Twitter (News - Alert) @PPHSUMMIT, Facebook (News - Alert) @PPHSUMMIT, and LinkedIn.


[ Back To TMCnet.com's Homepage ]